📰 Nasdaq Dffn News
Nasdaq Dffn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Dffn. Real-time updates on events, politics, business and more.
September 13, 2023
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Diffusion Pharmaceuticals stock opened at $4.40 on Friday. The firm has a 50 day moving average price of $4.64 and a […]
August 27, 2023
Research analysts at StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ DFFN opened at $4.40 on Friday. The firm has a 50 day moving average of $4.84 […]
August 21, 2023
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Shares of DFFN stock opened at $4.40 on Thursday. The company has a fifty day moving average price of $4.94 and […]
July 28, 2023
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research note released on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ DFFN opened at $3.13 on Monday. The firm has a market capitalization of $6.39 million, a price-to-earnings ratio of -0.41 […]
July 19, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ:DFFN opened at $3.05 on Friday. The business’s 50 day simple moving average is $3.58 and its two-hundred day […]
July 18, 2023
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 1,400 shares, a decline of 71.4% from the June 15th total of 4,900 shares. Based on an average daily trading volume, of 8,200 […]
July 17, 2023
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report released on Sunday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of DFFN stock opened at $3.01 on Friday. The business has a 50 day moving average of $3.61 and a two-hundred day moving […]
July 4, 2023
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 4,900 shares, a decline of 23.4% from the May 31st total of 6,400 shares. Based on an average trading volume of 8,000 shares, the days-to-cover ratio is […]
June 25, 2023
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Thursday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.53 on Thursday. Diffusion Pharmaceuticals has a fifty-two week low of $3.42 and a fifty-two week high of $8.74. The […]
June 16, 2023
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the recipient of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 6,400 shares, a decrease of 34.0% from the May 15th total of 9,700 shares. Approximately 0.3% of the company’s stock are sold short. Based […]